HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Isabelle Bernard-Pierrot Selected Research
Isabelle Bernard-Pierrot Research Topics
Disease
17
Urinary Bladder Neoplasms (Bladder Cancer)
06/2023 - 01/2011
15
Neoplasms (Cancer)
06/2023 - 08/2002
6
Carcinoma (Carcinomatosis)
01/2023 - 01/2004
5
Neoplasm Metastasis (Metastasis)
01/2023 - 08/2002
3
Breast Neoplasms (Breast Cancer)
03/2014 - 09/2008
2
Non-Muscle Invasive Bladder Neoplasms
06/2023 - 01/2023
2
Carcinogenesis
01/2023 - 08/2002
1
Ureteral Neoplasms (Ureteral Cancer)
01/2022
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2021
1
Renal Cell Carcinoma (Grawitz Tumor)
01/2021
1
Melanoma (Melanoma, Malignant)
01/2021
1
Sarcoma (Soft Tissue Sarcoma)
01/2021
1
Tertiary Lymphoid Structures
01/2021
1
Fibrosis (Cirrhosis)
12/2020
1
Virus Diseases (Viral Diseases)
11/2018
1
Adenocarcinoma
11/2013
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2013
1
Ovarian Neoplasms (Ovarian Cancer)
01/2013
1
Prostatic Neoplasms (Prostate Cancer)
05/2011
1
Neuroblastoma
01/2004
1
Glioma (Gliomas)
01/2004
Drug/Important Bio-Agent (IBA)
6
Proteins (Proteins, Gene)
FDA Link
06/2023 - 08/2002
4
Phenobarbital (Luminal)
FDA Link
01/2023 - 11/2014
4
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
09/2017 - 08/2002
4
pleiotrophin (HARP)
IBA
05/2011 - 08/2002
3
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
08/2022 - 12/2004
3
Biomarkers (Surrogate Marker)
IBA
01/2021 - 09/2017
3
ErbB Receptors (EGF Receptor)
IBA
10/2015 - 10/2013
3
Heparin (Liquaemin)
FDA Link
Generic
05/2011 - 08/2002
2
Ligands
IBA
06/2023 - 09/2017
2
RNA (Ribonucleic Acid)
IBA
01/2023 - 01/2011
2
Phosphotransferases (Kinase)
IBA
11/2018 - 09/2017
2
Messenger RNA (mRNA)
IBA
01/2018 - 09/2017
2
Small Interfering RNA (siRNA)
IBA
03/2014 - 11/2013
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
06/2023
1
uridylyl-(3'-5')-guanosine
IBA
06/2023
1
Carcinogens
IBA
01/2023
1
Transcription Factors (Transcription Factor)
IBA
01/2023
1
Vimentin
IBA
01/2023
1
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
01/2022
1
Interleukin-7 (Interleukin 7)
IBA
12/2021
1
Proteome
IBA
01/2021
1
Interferons
IBA
01/2021
1
Immune Checkpoint Inhibitors
IBA
01/2021
1
mesoglycan
IBA
12/2020
1
c-Mer Tyrosine Kinase
IBA
01/2019
1
Insulin (Novolin)
FDA Link
09/2017
1
Growth Factor Receptors
IBA
09/2017
1
Carrier Proteins (Binding Protein)
IBA
09/2017
1
Decorin
IBA
12/2013
1
Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)
IBA
10/2013
1
Antibodies
IBA
01/2013
1
Monoclonal Antibodies
IBA
01/2013
1
Integrins
IBA
01/2013
1
Blocking Antibodies
IBA
01/2013
1
Peptides (Polypeptides)
IBA
05/2011
1
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
09/2008
1
Phosphoprotein Phosphatases (Phosphatases, Protein)
IBA
09/2008
1
Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)
IBA
12/2004
1
Protein Isoforms (Isoforms)
IBA
12/2004
1
Insulin-Like Growth Factor II (Somatomedin A)
IBA
12/2004
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
12/2004
1
Midkine
IBA
01/2004
1
N 30
IBA
01/2004
1
Angiogenesis Inducing Agents (Angiogenesis Factor)
IBA
08/2002
1
Amino Acids
FDA Link
08/2002
Therapy/Procedure
7
Therapeutics
01/2022 - 01/2013
2
Radiotherapy
08/2022 - 12/2020
2
Immunotherapy
01/2022 - 01/2021
1
Drug Therapy (Chemotherapy)
01/2022
1
Cystectomy
12/2020